SOURCE: Fresh Start Private Management, Inc.

Fresh Start Private Management,  Inc.

December 10, 2013 08:00 ET

Fresh Start Private Management, Inc. Announces CEO Share Purchase Plan

LOS ANGELES, CA--(Marketwired - Dec 10, 2013) - Fresh Start Private Management Inc. (OTCQB: CEYY), a leader in alcohol treatment and rehabilitation programs, announced today that Kent Emry, Chief Executive Officer of Fresh Start Private Management, Inc. has purchased shares on the open market using personal funds and intends to purchase up to $50,000 of the Company's stock in open market transactions from the date of this announcement to January 31, 2014, subject to the restrictions of and consistent with the Company's securities trading policy.

"I'm choosing to buy company shares reflecting the confidence I have in the long-term growth prospects of Fresh Start Private," said Kent Emry. "I too am a shareholder and will stay committed to increasing the value of our company for all shareholders as we execute our plan to bring our treatment program to the masses."

Under this plan, Mr. Emry may purchase up to $50,000 of the Company's common stock, subject to certain conditions. The timing and actual number of shares purchased will depend on a variety of factors including regulatory restrictions on price, manner, timing, and volume, corporate and other regulatory requirements and other market conditions in an effort to minimize the impact of the purchases on the market for the stock. There can be no assurance that any shares will be purchased either through plan or otherwise.

About Fresh Start Private

Fresh Start Private Management, Inc. (OTCQB: CEYY) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a highly effective program consisting of two main components used by various alcohol addiction clinics in the US. Clinic reports show that the treatment program has an 85% success rate with individuals that complete the program. The first component of the program consists of an outpatient implant procedure performed by a licensed physician that delivers targeted, therapeutic levels of the drug Naltrexone, an opiate antagonist that significantly reduces physical cravings for alcohol, into the body. The second component of the program developed by Fresh Start Private is a one on one coaching program specifically tailored for the treatment of alcoholism. For more information on CEYY, please visit

Safe Harbor Statement

The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.

Contact Information

  • Investor Relations Contact:
    Maximum Performance Advisors, Inc.